* Companies: o Arena Pharmaceuticals, Inc. o Cytori Therapeutics, Inc. o Dendreon Corp. * Topics: o Investing Ideas & Strategies
A number of hot 2010 biotech names are also surging today on sparse news. Dendreon (NASDAQ: DNDN - News) is approaching pre-approval pricing after giving up gains on the FDA approval of its prostate cancer vaccine. Arena Pharmaceuticals (NASDAQ: ARNA - News), which is banking on the approval of its weightloss drug following a negative FDA panel vote for Vivus's (NASDAQ: VVUS - News) Qnexa, is ahead by more than 10% today on no news. Meanwhile, Jazz Pharmaceuticals (NASDAQ: JAZZ - News), MannKind (NASDAQ: MNKD - News), and Cytori Therapeutics, Inc. (NASDAQ: CYTX - News) are also among the day's big winners.